References
- Maeshima K, Utsugi-Sutoh N, Otani T, Kishi S. Progres- sive enlargement of scattered photocoagulation scars in diabetic retinopathy. Retina. 2004;24(4):507–511.
- Shatz H, Madeira D, Mc Donald HR et al. Progressive enlargement of laser scars following grid laser photocoag- ulation for diffuse diabetic macular edema. Arch Ophthal- mol. 1991;109:1549–1551.
- Morgan CM, Shatz H. Atrophic creep of the retinal pigment epithelium after focal macular photocoagulation. Ophthal- mology. 1989;96:96–103.
- Framme C, Brinkmann R, Birngruber R, Roider J. Auto- fluorescence imaging after selective RPE laser treatment in macular diseases and clinical outcome: a pilot study. Br J Ophthalmol. 2002;86:1099–1106.
- Wilson AS, Hobbs BG, Shen W-Y et al. Argon Laser pho- tocoagulation-induced modification of gene expression in the retina. Invest Ophthalmol Vis Sci. 2003;44:1426–1434.
- Mainster MA, White TJ, Tips JH, Wilson PW. Retinal- temperature increases produced by intense light sources. J Opt Soc Am. 1970;60:264–270.
- Mainster MA. Decreasing retinal photocoagulation damage: Principles and techniques. Semin Ophthalmol. 1999;14(4):200–209.
- Schushereba ST, Bowman PD, Stuck BE. Protection of ARPE-19 cells against thermal injury: Evaluation of thermal preconditioning and Herbimycin A treatment by cell viability and cDNA arrays. Invest Ophthal Vis Sci. 2003;44: ARVOE-Abstract 2281.
- Midena E, de Belvis V, Lo Giudice G, Pilotto E, Piermarocchi S. Transpupillary thermotherapy of retinal angiomatous proliferation in age-related macular degener- ation. Invest Ophthal Vis Sci. 2002;43: ARVOE-Abstract 4417.
- Mainster MA, Reichel E. Transpupillary thermotherapy: Long-pulse photocoagulation, apoptosis and heat shock proteins. Ophthalmic Surg Lasers. 2000;31:359–373.
- Ito Y, Yoneya S, Takita H, Ito M, Mori K. Upregulation of antiangiogenic genes by transpupillary thermotherapy. Invest Ophthal Vis Sci. 2004;45: ARVOE-Abstract 706.
- Falsini B, Focosi F, Molle F, Manganelli C, Iarossi G, Fadda A, Dorin G, Mainster MA. Monitoring retinal function during transpupillary thermotherapy for occult choroidal neovascularization in age-related macular degeneration. Invest Ophthal Vis Sci. 2003;44:2133–2140.
- Pirozzi E, Coccimiglio F, Manganelli C et al. Retinal func- tion following transpupillary thermotherapy for occult choroidal neovascularization in age-related macular degen- eration: a short-term study by focal ERGs. Invest Ophthal Vis Sci. 2004;45: ARVOE-Abstract 5128.
- Midena E, Radin P, Pilotto E, Maritan V, Piermarocchi S. Macular subthreshold transpupillary thermotherapy does not impair macular function. Invest Ophthal Vis Sci. 2003;44: ARVOE-Abstract 1785.
- Reichel E, Berrocal AM, Ip M, Kroll AJ, Desai V, Duker JS, Puliafito CA. Transpupillary thermotherapy of occult subfoveal choroidal neovascularization in patients with age-related macular degeneration. Ophthalmology. 1999; 106:1908–1914.
- Newsom RSB, McAlister JC, Saeed M, McHugh JDA. Transpupillary thermotherapy for the treatment of choroidal neovascularisation. Br J Ophthalmol. 2001;85:173–178.
- Park CH, Duker JS, Mainster MA, Puliafito CA, Reichel E. Transpupillary thermotherapy (TTT) of occult choroidal neovascularization: A retrospective, noncomparative case series of fifty-seven eyes. Semin Ophthlamol. 2001;16(2): 66–69.
- Friberg TR, Pandya A, Kourosh N. Transpupillary ther- motherapy (TTT) for age-related macular degeneration. Semin Ophthlamol. 2001;16(2):70–80.
- Ahuja RM, Benner JD, Schwartz JC, Butler JW, Steidl SM. Efficacy of transpupillary thermotherapy (TTT) in the treat- ment of occult subfoveal choroidal neovascularization in age-related macular degeneration. Semin Ophthlamol. 2001;16(2):81–85.
- Kim JE, Perkins SL, Schwiesow T, Connor Jr TB, Han DP. Transpupillary thermotherapy of occult choroidal neovas- cularization in age-related macular degeneration. Semin Ophthlamol. 2001;16(2):86–89.
- Thach AB, Sipperley JO, Dugel PU, Sneed SR, Park DW, Cornelius J. Large-spot size transpupillary thermotherapy for the treatment of occult choroidal neovascularization associated with age-related macular degeneration. Arch Ophthalmol. 2003;121(6);817–820.
- Algvere PV, Libert C, Lindgärde G, Seregard S. Transpupil- lary thermotherapy of predominantly occult choroidal neo- vascularization in age-related macular degeneration with 12 months follow-up. Acta Ophthalmol Scand. 2003;81:110– 117.
- Algvere PV, Libert C, Seregard S. Transpupillary ther- motherapy of occult CNV with no or minimally classic CNV in age-related macular degeneration. Semin Ophth- lamol. 2001;16(2):90–96.
- Kumar A, Prakash G, Singh RP. Transpupillary ther- motherapy for idiopathic subfoveal choroidal neovascular- ization. Acta Ophthalmol Scan. 2004;82:205–208.
- Verma L, Tewari HK, Nainiwal S, Ravindranathan J. Transpupillary thermotherapy in subfoveal choroidal neo- vascular membrane secondary to age-related macular degeneration. Indian J Ophthalmol. 2004;52:35–40.
- Agarwal M, Shanmugam MP, Gopal L et al. Transpupillary thermotherapy for choroidal neovascular membrane in age- related macular degeneration. Indian J Ophthalmol. 2004;52:45–49.
- Sharma T, Shah N, Gopal L et al. Indocyanine green dye- enhanced transpupillary thermotherapy of classic subfoveal choroidal neovascularization. Ophthalmic Surg Lasers Imaging. 2004;35:197–206.
- Hamon F, Salvetti P, Goeminne P, Cardoen L. Modified transpupillary thermotherapy (TTT) for submacular serous detachment in chronic serous choroidopathy (CSC). Invest Ophthal Vis Sci. 2004;45: ARVOE-Abstract 531.
- Takasu I, Shiraga F, Hosoki M, Okabe H, Ohtsuki H. Transpupillary thermotherapy for chronic central serous chorioretinopathy. Invest Ophthal Vis Sci. 2004;45: ARVOE-Abstract 533.
- Sivagnanavel V, Chong V. Diffuse laser for drusen reduc- tion in high risk age-related maculopathy. Invest Ophthal Vis Sci. 2004;45: ARVOE-Abstract 3097.
- Olk RJ, Friberg TR, Stickney KL, Akduman L, Wong KL, Chen MC, Levy MH, Garcia CA, Morse LS. Therapeutic benefits of infrared (810-nm) diode laser macular grid pho- tocoagulation in prophylactic treatment of nonexudative age-related macular degeneration. Ophthalmology. 1999; 106:2082–2090.
- Akduman L, Olk RJ. Subthreshold (invisible) modified grid diode laser photocoagulation in diffuse diabetic macular edema (DDME). Ophthalmic Surg Lasers. 1999;30:706– 714.
- Olk RJ, Akduman L. Minimal intensity diode laser (810 nanometer) photocoagulation (MIP) for diffuse diabetic macular edema (DDME). Semin Ophthalmol. 2001;16(1): 25–30.
- Dorin G. Subthreshold and micropulse diode laser photocoagulation. Semin Ophthalmol. 2003;18(3):147– 143.
- Friberg TR, Karatza EC. The treatment of macular disease using a micropulsed and continuous wave 810-nm diode laser. Ophthalmology. 1997;104:2030–2038.
- Moorman CM, Hamilton AMP. Clinical applications of the micropulse diode laser. Eye. 1999;13:145–150.
- Stanga PE, Reck AC, Hamilton AMP. Micropulse laser in the treatment of diabetic macular edema. Semin Ophthal- mol. 1999;14(4);210–213.
- Laursen ML, Moeller F, Sander B, Sjoelie AK. Subthresh- old micropulse diode laser treatment in diabetic macular oedema. Br J Ophthalmol. 2004;88:1173–1179.
- Luttrull JK, Musch DC, Mainster MA. Subvisible diode micropulse photocoagulation for the treatment of clinically significant macular edema. Br J Ophthalmol. 2004;88 (in press).
- Grigorian RA, Zarbin MA, Brimacombe R, Tutela A, Roy M, Bhagat N. Comparison of subthreshold micropulse diode laser photocoagulation with conventional laser pho- tocoagulation for clinically significant macular edema in diabetic patients. Invest Ophthal Vis Sci. 2004;45: ARVOE-Abstract 4067.
- Avery RL, Pieramici DJ, Nasir MA, Rhodes K, Robbins E. Micropulse laser for diabetic macular edema: A prospec- tive pilot study. Invest Ophthal Vis Sci. 2004;45: ARVOE- Abstract 4143.
- McHugh JA, Tandon A, el-Ghonemy K. Micropulsed diode laser for diabetic macular edema. Invest Ophthal Vis Sci. 2002;43: ARVOE-Abstract 562.
- Friberg TR. Infrared micropulsed laser treatment for diabetic macular edema – subthreshold versus threshold lesions. Semin Ophthalmol. 2001;16(1):19–24.
- Ricci F, Missiroli F, Cerulli L. Indocyanine green dye- enhanced micropulsed diode laser: A novel approach to subthreshold RPE treatment in a case of central serous chorioretinopathy. Eur J Ophthalmol. 2004;14:74–82.
- Bandello F, Lanzetta P, Furlan F, Polito A. Micropulse diode laser treatment of idiopatic central serous chorioretinopa- thy. A pilot study. Invest Ophthal Vis Sci. 2003;44: ARVOE-Abstract 4858.
- Lanzetta P, Dorin G, Pirracchio A, Bandello F. Theoretical bases of non-ophthalmoscopically visible endpoint photo- coagulation. Semin Ophthalmol. 2001;16(1):8–11.
- Rodanant N, Friberg T, Cheng L, Aurora A, Bartsch DU, Freeman W. Predictors of drusen after infrared (810) diode laser macular grid photocoagulation for nonexudative age- related macular degeneration. Am J Ophthalmol. 2002;134:577–585.
- Salvetti P, Rosen JM, Reichel E. Subthreshold infrared foot-printing with indocyanine green for localizing low- intensity infrared photocoagulation. Ophthalmic Surg Lasers Imaging. 2003;34:44–48.